157 related articles for article (PubMed ID: 25650725)
1. Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality.
Levi M
J Thromb Haemost; 2015 Apr; 13(4):505-7. PubMed ID: 25650725
[No Abstract] [Full Text] [Related]
2. Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effective.
Fink MP
Crit Care Med; 2013 Sep; 41(9):2221-3. PubMed ID: 23979366
[No Abstract] [Full Text] [Related]
3. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.
Ito T; Thachil J; Asakura H; Levy JH; Iba T
Crit Care; 2019 Aug; 23(1):280. PubMed ID: 31416465
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
[TBL] [Abstract][Full Text] [Related]
5. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.
Yamakawa K; Fujimi S; Mohri T; Matsuda H; Nakamori Y; Hirose T; Tasaki O; Ogura H; Kuwagata Y; Hamasaki T; Shimazu T
Crit Care; 2011; 15(3):R123. PubMed ID: 21569368
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
Vincent JL; Ramesh MK; Ernest D; LaRosa SP; Pachl J; Aikawa N; Hoste E; Levy H; Hirman J; Levi M; Daga M; Kutsogiannis DJ; Crowther M; Bernard GR; Devriendt J; Puigserver JV; Blanzaco DU; Esmon CT; Parrillo JE; Guzzi L; Henderson SJ; Pothirat C; Mehta P; Fareed J; Talwar D; Tsuruta K; Gorelick KJ; Osawa Y; Kaul I
Crit Care Med; 2013 Sep; 41(9):2069-79. PubMed ID: 23979365
[TBL] [Abstract][Full Text] [Related]
7. The obstacles that should be overcome to develop new anticoagulants for severe sepsis.
Iba T
Crit Care Med; 2014 Mar; 42(3):e248-9. PubMed ID: 24534987
[No Abstract] [Full Text] [Related]
8. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
[TBL] [Abstract][Full Text] [Related]
9. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Murao A; Kato T; Yamane T; Honda G; Eguchi Y
Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
[TBL] [Abstract][Full Text] [Related]
10. Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation.
Kotake K; Hongo T; Tahira A; Niimi N; Haisa I; Kawakami Y
Biol Pharm Bull; 2021 May; 44(5):605-610. PubMed ID: 33612566
[TBL] [Abstract][Full Text] [Related]
11. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
Thromb Res; 2023 Jun; 226():165-172. PubMed ID: 37182388
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of recombinant thrombomodulin in septic patients].
Eguchi Y
Rinsho Byori; 2011 Feb; Suppl 147():177-80. PubMed ID: 21761768
[No Abstract] [Full Text] [Related]
15. Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation.
Iba T
Crit Care; 2015 May; 19(1):233. PubMed ID: 26002185
[No Abstract] [Full Text] [Related]
16. Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient.
Morino K; Honma Y; Kumei S; Watanabe T; Kume K; Yoshikawa I; Harada M
Intern Med; 2018 Nov; 57(21):3079-3085. PubMed ID: 29877275
[TBL] [Abstract][Full Text] [Related]
17. [How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers].
Eguchi Y; Yoshida T; Okabe H
Rinsho Byori; 2011 Feb; Suppl 147():213-5. PubMed ID: 21761775
[No Abstract] [Full Text] [Related]
18. Neuroleptic malignant syndrome-induced massive coagulopathy treated by recombinant human soluble thrombomodulin.
Hayashida K; Fujishima S; Nakaya N; Abe S; Shiroshita-Takeshita A; Hori S
Am J Emerg Med; 2013 Mar; 31(3):636.e1-3. PubMed ID: 23218866
[No Abstract] [Full Text] [Related]
19. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
[TBL] [Abstract][Full Text] [Related]
20. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
